Diltiazem Hcl
Brand name: Diltiazem 24hr Er (Cd)
Rank #192 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$75.9M
Total Cost
1,846,124
Total Claims
$75.9M
Total Cost
64,559
Prescribers
$41
Cost per Claim
258,143
Beneficiaries
3,989,346
30-Day Fills
$1,176
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$75.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $75.9M total
Top Prescribers of Diltiazem Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jeffrey Chung | Cardiology | New York, NY | 14 | $36K |
| 2 | Seth Mcclennen | Clinical Cardiac Electrophysiology | South Weymouth, MA | 476 | $32K |
| 3 | George So | Cardiology | Jamestown, NY | 423 | $28K |
| 4 | Alan Simon | Cardiology | Ridgewood, NJ | 13 | $25K |
| 5 | Prakash Shah | Cardiology | Milwaukee, WI | 530 | $25K |
| 6 | Daniel Colangelo | Internal Medicine | Harrison, NY | 13 | $23K |
| 7 | Henry Chong | Cardiology | Greenville, OH | 763 | $23K |
| 8 | Zaki Lababidi | Cardiology | Gilbert, AZ | 276 | $23K |
| 9 | Mark Lampert | Cardiology | Skokie, IL | 12 | $22K |
| 10 | Robert Kayser | Cardiology | Sea Girt, NJ | 305 | $20K |
| 11 | Alexander Delvecchio | Clinical Cardiac Electrophysiology | Greenwich, CT | 394 | $20K |
| 12 | Mukesh Gopalakrishnan | Interventional Cardiology | Tucson, AZ | 472 | $19K |
| 13 | Wilmore Finerman | Cardiology | Rye, NY | 196 | $19K |
| 14 | Matthew Weinberg | Cardiology | Waukesha, WI | 337 | $19K |
| 15 | Michael Levine | Cardiology | New Hyde Park, NY | 234 | $18K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 189 | Sod Phenylbutyrat/Taurursodiol (Relyvrio) | $77.0M | 6,152 |
| 190 | Pravastatin Sodium (Pravastatin Sodium) | $76.8M | 4,033,829 |
| 191 | Lanadelumab-Flyo (Takhzyro) | $76.5M | 1,670 |
| 192 | Diltiazem Hcl (Diltiazem 24hr Er (Cd)) | $75.9M | 1,846,124 |
| 193 | Carvedilol (Carvedilol) | $75.6M | 6,390,691 |
| 194 | Cannabidiol (Cbd) (Epidiolex) | $75.5M | 15,726 |
| 195 | Eculizumab (Soliris) | $74.6M | 1,794 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology